共 153 条
[11]
Jordan JM(2015)Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis Curr Med Res Opin 31 1041-5
[12]
Katz JN(2012)American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip and knee Arthritis Care Res (Hoboken) 64 465-474
[13]
Kremers HM(2014)OARSI guidelines for the non-surgical management of knee osteoarthritis Osteoarthr Cartil 22 363-388
[14]
Wolfe F(2016)A consensus statement on the European Society for Clinical and Economic Aspects of osteoporosis and osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis – from evidence-based medicine to the real-life setting Semin Arthritis Rheum 45 S3-11
[15]
Vos T(2000)Efficacy of a combination of FCHG49™ glucosamine hydrochloride, TRH122™ low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis Osteoarthr Cartil 8 343-350
[16]
Flaxman AD(2010)Effects of glucosamine, chondroitin, or placebo in patients with osteoartrhtis of hip or knee: network meta-analysis BMJ 341 C4675-44
[17]
Naghavi M(2015)Effectiveness and safety of glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of knee Sci Rep 5 16827-260
[18]
Lozano R(2016)Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib Ann Rheum Dis 75 37-11
[19]
Michaud C(2008)Total joint replacement after glucosamine sulfate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from previous 3-year, randomised, placebo-controlles trials Osteoarthr Cartil 16 254-undefined
[20]
Ezzati M(2010)The effects of oral glucosamine on joint health: is a change in research approach needed? Osteoarthr Cartil 18 5-undefined